Switch to:

Intra-Cellular Therapies Net Income From Continuing Operations

: $-206.89 Mil (TTM As of Sep. 2020)
View and export this data going back to 2013. Start your Free Trial

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Intra-Cellular Therapies's net income from continuing operations for the three months ended in Sep. 2020 was $-55.18 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Sep. 2020 was $-206.89 Mil.


Intra-Cellular Therapies Net Income From Continuing Operations Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Intra-Cellular Therapies Annual Data
Dec12 Mar13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Net Income From Continuing Operations Premium Member Only Premium Member Only Premium Member Only -104.79 -116.43 -97.77 -155.13 -147.72

Intra-Cellular Therapies Quarterly Data
Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
Net Income From Continuing Operations Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -34.86 -40.58 -47.41 -63.71 -55.18

Intra-Cellular Therapies Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Sep. 2020 was -40.583 (Dec. 2019 ) + -47.411 (Mar. 2020 ) + -63.712 (Jun. 2020 ) + -55.184 (Sep. 2020 ) = $-206.89 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Intra-Cellular Therapies Net Income From Continuing Operations Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)